Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal

Objective To investigate the relationship between serum miR-199a-5p and miR-378a-3p levels and the recurrence of infants with proliferative facial hemangioma relapsed after propranolol withdrawal in infants. Methods Ninety-three infants with proliferative facial hemangioma were selected, all of whom...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: GUO Yan, ZHANG Kai, FAN Xuhui, LI Lifeng
Formato: article
Lenguaje:ZH
Publicado: Editorial Department of Journal of Prevention and Treatment for Stomatological Diseases 2022
Materias:
R
Acceso en línea:https://doaj.org/article/4ae03ff196204d588a494b32a035243a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4ae03ff196204d588a494b32a035243a
record_format dspace
spelling oai:doaj.org-article:4ae03ff196204d588a494b32a035243a2021-11-25T07:18:56ZRelationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal10.12016/j.issn.2096-1456.2022.02.0042096-1456https://doaj.org/article/4ae03ff196204d588a494b32a035243a2022-02-01T00:00:00Zhttp://www.kqjbfz.com/CN/10.12016/j.issn.2096-1456.2022.02.004https://doaj.org/toc/2096-1456Objective To investigate the relationship between serum miR-199a-5p and miR-378a-3p levels and the recurrence of infants with proliferative facial hemangioma relapsed after propranolol withdrawal in infants. Methods Ninety-three infants with proliferative facial hemangioma were selected, all of whom received propranolol treatment. The recurrence of the hemangioma after treatment was followed up, and the children were divided into a recurrence group (23 patients) and a nonrecurrence group (70 patients). Venous blood was collected before and after treatment, and the serum levels of miR-199a-5p and miR-378a-3p were detected by qRT-PCR, and the relationship between the serum levels of miR-199a-5p and miR-378a-3p and the recurrence of proliferative facial hemangioma relapsed after propranolol withdrawal in infants was analyzed. Results The serum expressions levels of miR-199a-5p and miR-378a-3p in non-relapsed group were increased after treatment compared with before treatment (P < 0.05), and there was no significant difference in the levels of miR-199a-5p and miR-378a-3p in the serum of the recurrence group after treatment compared with before treatment (P > 0.05). After treatment, the levels of miR-199a-5p and miR-378a-3p in the serum of the recurrence group were lower than those of the nonrecurrence group (P < 0.05). After treatment, the serum levels of miR-199a-5p and miR-378a-3p in patients with Ⅲ ~Ⅳ Norm grade hemangioma were higher than those in patients with Ⅰ~Ⅱ Norm grade hemangioma (P < 0.05). Logistic regression analysis showed that the low expression of miR-199a-5p, low expression of miR-378a-3p and tumor grade Ⅰ~Ⅱ after treatment were risk factors for the recurrence of proliferative facial hemangioma after propranolol withdrawal in infants (P < 0.05). Conclusion Low serum levels of miR-199a-5p and miR-378a-3p are associated with the recurrence of proliferative facial hemangioma after propranolol withdrawal in infants.GUO YanZHANG Kai FAN XuhuiLI LifengEditorial Department of Journal of Prevention and Treatment for Stomatological Diseasesarticlemicro ribonucleic acidmir-199a-5pmir-378a-3ppropranololinfanthemangiomarecurrenceendothelial cell proliferationMedicineRZH口腔疾病防治, Vol 30, Iss 2, Pp 97-102 (2022)
institution DOAJ
collection DOAJ
language ZH
topic micro ribonucleic acid
mir-199a-5p
mir-378a-3p
propranolol
infant
hemangioma
recurrence
endothelial cell proliferation
Medicine
R
spellingShingle micro ribonucleic acid
mir-199a-5p
mir-378a-3p
propranolol
infant
hemangioma
recurrence
endothelial cell proliferation
Medicine
R
GUO Yan
ZHANG Kai
FAN Xuhui
LI Lifeng
Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal
description Objective To investigate the relationship between serum miR-199a-5p and miR-378a-3p levels and the recurrence of infants with proliferative facial hemangioma relapsed after propranolol withdrawal in infants. Methods Ninety-three infants with proliferative facial hemangioma were selected, all of whom received propranolol treatment. The recurrence of the hemangioma after treatment was followed up, and the children were divided into a recurrence group (23 patients) and a nonrecurrence group (70 patients). Venous blood was collected before and after treatment, and the serum levels of miR-199a-5p and miR-378a-3p were detected by qRT-PCR, and the relationship between the serum levels of miR-199a-5p and miR-378a-3p and the recurrence of proliferative facial hemangioma relapsed after propranolol withdrawal in infants was analyzed. Results The serum expressions levels of miR-199a-5p and miR-378a-3p in non-relapsed group were increased after treatment compared with before treatment (P < 0.05), and there was no significant difference in the levels of miR-199a-5p and miR-378a-3p in the serum of the recurrence group after treatment compared with before treatment (P > 0.05). After treatment, the levels of miR-199a-5p and miR-378a-3p in the serum of the recurrence group were lower than those of the nonrecurrence group (P < 0.05). After treatment, the serum levels of miR-199a-5p and miR-378a-3p in patients with Ⅲ ~Ⅳ Norm grade hemangioma were higher than those in patients with Ⅰ~Ⅱ Norm grade hemangioma (P < 0.05). Logistic regression analysis showed that the low expression of miR-199a-5p, low expression of miR-378a-3p and tumor grade Ⅰ~Ⅱ after treatment were risk factors for the recurrence of proliferative facial hemangioma after propranolol withdrawal in infants (P < 0.05). Conclusion Low serum levels of miR-199a-5p and miR-378a-3p are associated with the recurrence of proliferative facial hemangioma after propranolol withdrawal in infants.
format article
author GUO Yan
ZHANG Kai
FAN Xuhui
LI Lifeng
author_facet GUO Yan
ZHANG Kai
FAN Xuhui
LI Lifeng
author_sort GUO Yan
title Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal
title_short Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal
title_full Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal
title_fullStr Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal
title_full_unstemmed Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal
title_sort relationship between serum mir-199a-5p and mir-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal
publisher Editorial Department of Journal of Prevention and Treatment for Stomatological Diseases
publishDate 2022
url https://doaj.org/article/4ae03ff196204d588a494b32a035243a
work_keys_str_mv AT guoyan relationshipbetweenserummir199a5pandmir378a3plevelsandrecurrenceofinfantswithproliferativefacialhemangiomaafterpropranololwithdrawal
AT zhangkai relationshipbetweenserummir199a5pandmir378a3plevelsandrecurrenceofinfantswithproliferativefacialhemangiomaafterpropranololwithdrawal
AT fanxuhui relationshipbetweenserummir199a5pandmir378a3plevelsandrecurrenceofinfantswithproliferativefacialhemangiomaafterpropranololwithdrawal
AT lilifeng relationshipbetweenserummir199a5pandmir378a3plevelsandrecurrenceofinfantswithproliferativefacialhemangiomaafterpropranololwithdrawal
_version_ 1718413616191897600